Riverside Medical Center
Internal Medicine residency · Kankakee, IL · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Kaiser Permanente Riverside Medical Center's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About Kaiser Permanente Riverside Medical Centerinstitution-wide internal medicine research
Internal Medicine publications from Kaiser Permanente Riverside Medical Center and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
9
works per year
121st of 134 internal medicine residency programs
+11.8%
2-year growth
48th of 132 internal medicine residency programs
25.9%
in top 10% of field (works before 2025)
46th of 122 internal medicine residency programs
55.6%
cited above world average
6th of 122 internal medicine residency programs
Works per year · * 2026 so far
Oncology · 14Cardiology and Cardiovascular Medicine · 6Gastroenterology · 6Infectious Diseases · 5Pulmonary and Respiratory Medicine · 4
Internal Medicine research topics at Kaiser Permanente Riverside Medical Center
Papers in the window; each links to the list on OpenAlex.
Most cited at Kaiser Permanente Riverside Medical Center since 2024
All internal medicine papers there on OpenAlex
- Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad Ezzeddine Allaf et al. · The Lancet Oncology · 2024 · PubMed · cited 101
- Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 StudyToni K. Choueiri et al. · The Lancet · 2024 · PubMed · cited 87
- Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinomaKarim Seif El Dahan et al. · JHEP Reports · 2025 · PubMed · cited 9
- A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial CancerRandy F. Sweis et al. · Clinical Cancer Research · 2024 · PubMed · cited 7
- Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancerAmrita Mukherjee et al. · Frontiers in Oncology · 2024 · PubMed · cited 6
- Comparison of mortality and cardiovascular complications due to COVID-19, RSV, and influenza in hospitalized children and young adultsSagya Khanal et al. · BMC Cardiovascular Disorders · 2024 · PubMed · cited 5
- Prevalence and Impact of Social Risk in Patients With Inflammatory Bowel Diseases: National Estimates From the United StatesSeo Hyun Kim et al. · Clinical Gastroenterology and Hepatology · 2025 · PubMed · cited 3
- Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID 19 Pandemic in an Integrated Healthcare Delivery SystemAmrita Mukherjee et al. · Cancer Management and Research · 2025 · PubMed · cited 3
- Neighborhood Income Disparities in Unplanned Hospital Admission and In-Hospital Outcomes Among Children with Congenital Heart DiseaseLaxmi Vilas Ghimire et al. · Pediatric Cardiology · 2024 · PubMed · cited 3
- Impact of the COVID-19 pandemic on cancer recurrence rates in patients with ovarian cancerAmrita Mukherjee et al. · Gynecologic Oncology Reports · 2025 · PubMed · cited 2